Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : MLSC Blood decontaminant recieves patent!!! -- Ignore unavailable to you. Want to Upgrade?

To: Cindy Powell who wrote (126)	10/24/1997 4:53:00 PM
From: Susumu	Read Replies (2) \| Respond to of 196

I am new here. I recently found this company's name in a Japanese trade newspaper, The Chemical Daily, which reported current situations surrounding Function Water (also known in Japan as "strong electrolyte acidic water??"). Some of its key points are: o A Japanese patent was issued in July to Miura Electron, a rather obscure Japanese company with the sales of $8 million or so. The original application was filed in 1988. o It is a material patent covering sterilizing water obtained by electrolysis of water. The water contains salt, and the claim specifies its acidity (pH) and how much the electric conductivity has to change before and after the electrolysis. o Many Japanese companies want to make equipment to generate "Function Water." Among them, Miura Electron and two other companies obtained the approval from the Ministry of Health this year, and started marketing. o Miura Electron has successfully negotiated licensing agreement with several equipment makers. o Miura has been actively promoting "function water" since 1989. In 1993 Government fund was made available and a Government laboratory was set up in 1994. o Mr. Kulas lectured in Japan in September at a symposium on function water, and presented the situation in the U.S. and MDI's various test results. o An accompanying talk on the experience at a National Medical Center seems to verify the claim of the effectiveness as a sterilizing medium. o On December 9 and 10, a symposium on function water will be held in Tokyo, and three presentations form the U.S. are in the program. I believe Mr. Kulas is well aware of the Japanese situation. But after reading the article, I have two broad comments to make. First, the patent protection. I haven't read any of MDI's patents, and what I say here is merely a conjecture, but if the latest patent, "Electrically Hydrolyzed Salines as Microbiocides," is specific to MDI-P, there could be a loop-hole to go around the patents. As reported above, many companies in Japan want to market this type of equipment. The key factor is how MLSC can prevent that to happen in the U.S. I don't think Miura has filed US application. Therefore MLSC doesn't seem to have to worry about it, now. Second, commercialization. Reading through the thread, there is no discussion of how to commercialize. Probably they have to tie up with a medical equipment company to produce and market the equipment. What is their approach? How many people do they have? Having found the concept intriguing, I went through the thread and enjoyed your highly focused and objective handling of the thread, somewhat unique among the threads I read so far. That's why I wrote this note although I haven't bought the stock yet. I'll keep an eye on the Japanese scene, and hope I can report once in a while.